Back to top

Connect Biopharma Holdings (CNTB) Receives a New Rating from Oppenheimer

In a report released today, Mazahir Alimohamed from Oppenheimer initiated coverage with a Buy rating on Connect Biopharma Holdings and a price targ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Connect Biopharma Holdings Limited Sponsored ADR (CNTB)